239 related articles for article (PubMed ID: 3191112)
1. Fibrin(ogen) peptide B beta 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets.
Chen CS; Chou SH; Thiagarajan P
Biochemistry; 1988 Aug; 27(16):6121-6. PubMed ID: 3191112
[TBL] [Abstract][Full Text] [Related]
2. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
3. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa.
Parise LV; Helgerson SL; Steiner B; Nannizzi L; Phillips DR
J Biol Chem; 1987 Sep; 262(26):12597-602. PubMed ID: 2957377
[TBL] [Abstract][Full Text] [Related]
4. The role of the RGD peptides and the gamma chain peptide of fibrinogen on fibrinogen binding to activated platelets.
Mohri H; Ohkubo T
Peptides; 1993; 14(2):353-7. PubMed ID: 8483813
[TBL] [Abstract][Full Text] [Related]
5. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
6. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
[TBL] [Abstract][Full Text] [Related]
7. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
8. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.
Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J
Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688
[TBL] [Abstract][Full Text] [Related]
9. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
Mohri H; Ohkubo T
Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271
[TBL] [Abstract][Full Text] [Related]
10. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
Rahman S; Lu X; Kakkar VV; Authi KS
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
[TBL] [Abstract][Full Text] [Related]
11. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ligand binding to glycoprotein IIb-IIIa (integrin alpha IIb beta 3) in isolated platelet membranes.
Smyth SS; Parise LV
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):749-58. PubMed ID: 7686366
[TBL] [Abstract][Full Text] [Related]
13. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein IIb peptide 656-667 mimics the fibrinogen gamma chain 402-411 binding site on platelet integrin GPIIb/IIIa.
Calvete JJ; Rivas G; Schäfer W; McLane MA; Niewiarowski S
FEBS Lett; 1993 Nov; 335(1):132-5. PubMed ID: 8243658
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
[TBL] [Abstract][Full Text] [Related]
16. Ca2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex.
Steiner B; Cousot D; Trzeciak A; Gillessen D; Hadváry P
J Biol Chem; 1989 Aug; 264(22):13102-8. PubMed ID: 2753902
[TBL] [Abstract][Full Text] [Related]
17. Interaction of beta 3 integrin-derived peptides 214-218 and 217-231 with alpha IIb beta 3 complex and with fibrinogen A alpha-chain.
Wierzbicka I; Kowalska MA; Lasz EC; Farrell DH; Budzynski AZ; Niewiarowski S
Thromb Res; 1997 Jan; 85(2):115-26. PubMed ID: 9058485
[TBL] [Abstract][Full Text] [Related]
18. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets.
Savage B; Ruggeri ZM
J Biol Chem; 1991 Jun; 266(17):11227-33. PubMed ID: 2040630
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen fragments and platelet dysfunction in uremia.
Kozek-Langenecker SA; Masaki T; Mohammad H; Green W; Mohammad SF; Cheung AK
Kidney Int; 1999 Jul; 56(1):299-305. PubMed ID: 10411706
[TBL] [Abstract][Full Text] [Related]
20. A discrete sequence in a platelet integrin is involved in ligand recognition.
D'Souza SE; Ginsberg MH; Matsueda GR; Plow EF
Nature; 1991 Mar; 350(6313):66-8. PubMed ID: 2002847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
